Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 2802 for:    Neoplasms, Germ Cell and Embryonal | Neuroendocrine Tumors
Previous Study | Return to List | Next Study

Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine Tumors (NET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01215578
Recruitment Status : Terminated (lack of recruitement)
First Posted : October 6, 2010
Last Update Posted : April 30, 2015
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2013
Actual Study Completion Date : December 2014